Neuroimaging of mitochondrial disease.

Division of Pediatric Neurology, Children's Hospital and Regional Medical Center/University of Washington, 4800 Sand Point Way NE, Seattle, WA 98105, USA.
Mitochondrion (Impact Factor: 3.52). 06/2008; 8(5-6):396-413. DOI: 10.1016/j.mito.2008.05.003
Source: PubMed

ABSTRACT Mitochondrial disease represents a heterogeneous group of genetic disorders that require a variety of diagnostic tests for proper determination. Neuroimaging may play a significant role in diagnosis. The various modalities of nuclear magnetic resonance imaging (MRI) allow for multiple independent detection procedures that can give important anatomical and metabolic clues for diagnosis. The non-invasive nature of neuroimaging also allows for longitudinal studies. To date, no pathonmonic correlation between specific genetic defect and neuroimaging findings have been described. However, certain neuroimaging results can give important clues that a patient may have a mitochondrial disease. Conventional MRI may show deep gray structural abnormalities or stroke-like lesions that do not respect vascular territories. Chemical techniques such as proton magnetic resonance spectroscopy (MRS) may demonstrate high levels of lactate or succinate. When found, these results are suggestive of a mitochondrial disease. MRI and MRS studies may also show non-specific findings such as delayed myelination or non-specific leukodystrophy picture. However, in the context of other biochemical, structural, and clinical findings, even non-specific findings may support further diagnostic testing for potential mitochondrial disease. Once a diagnosis has been established, these non-invasive tools can also aid in following disease progression and evaluate the effects of therapeutic interventions.

Download full-text


Available from: Russell P Saneto, Jul 04, 2015
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Leber hereditary optic neuropathy (LHON) is caused by point mutations in mitochondrial DNA (mtDNA), and is characterized by bilateral, painless sub-acute visual loss that develops during the second decade of life. Here we report the case of a five year old girl who presented with clinical and neuroradiological findings reminiscent of Leigh syndrome but carried a mtDNA mutation m.11778G>A (p.R340H) in the MTND4 gene usually observed in patients with LHON. This case is unusual for age of onset, gender, associated neurological findings and evolution, further expanding the clinical spectrum associated with primary LHON mtDNA mutations.
    Molecular Genetics and Metabolism 02/2011; 103(2):153-60. DOI:10.1016/j.ymgme.2011.02.014 · 2.83 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The most common mitochondrial DNA (mtDNA) mutations giving rise to Leigh syndrome reside in the MTATP6 gene. We report a rare mutation, m. 9185 T>C that gives rise to a progressive, but episodic pattern of neurological impairment with partial recovery. Disease progression corresponded to febrile viral illness and nuclear magnetic resonance imaging (MRI) changes. The patient displayed nearly 100% homoplasmy, while his asymptomatic mother was 30%. Phenotypically, exacerbations of muscle weakness with endurance intolerance, dysarthric speech, ataxia, and eyelid ptosis accompanied febrile viral illness. This case demonstrates an episodic pattern of febrile illness-induced disease exacerbation with corresponding MRI changes.
    Mitochondrion 08/2010; 10(5):567-72. DOI:10.1016/j.mito.2010.05.006 · 3.52 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Dyslexia is a very common disorder among school children, with a prevalence ranging from 5% to12% in Western countries based on the various evaluation standards used for diagnosis and phenotype assessment. There is strong evidence from familial and twin studies indicating that the disorder has a genetic component. Although linkage analysis and association studies have identified potential risk loci located on chromosomes 1, 2, 3, 4, 6, 11, 12, 13, 15, 17, 18, and X, the lod scores are only marginally significant and the susceptible regions are broad and flat. To date, only DCDC2, KIAA0319, ROBO1, DYX1C1 PCNT, DIP2A, S100B, PRMT2, MRPL19 and C20RF3 have been reported as susceptibly involved genes; however, some of these results are controversial and despite intensive studies, gene prediction is extremely challenging. In silico cloning provides an efficient alternative for the discovery of possible candidate genes. Here, we explore the possibility of predicting the genes that might contribute to dyslexia using in silico cloning. We use the dyslexia candidate region on 2p11 as an example, where forty-two out of sixty genes have known functions assigned by the Ensembl Genome Browser. Three genes, namely, SUCLG1, IMM T and RM35_HUMAN are correlated with mitochondrial function and it is suggested, based on aspects of the physiology of dyslexia, that mutations in these genes may be important; specific information on these genes is described.